Nutex Health, Inc.
Built from the SEC filing index the day the filing landed. The figures below are the issuer's own from Form D; AltStreet's analysis, sponsor link and data flags follow when the entity is enriched.
Raised
$3M
Investors
13
Min Invest
$50,000
Is this your company or fund? Claim this page free, or verify it and carry the Verified Issuer mark.
What this filing shows
·Every sentence is a value as filed on SEC Form D
Nutex Health, Inc. is a Delaware corporation that first filed a Form D on November 13, 2019 and most recently amended it on October 17, 2023 in the Hospitals and Physicians industry group. The offering claims Rule 506(b) and covers debt. Nutex Health, Inc. reported $3,090,000 sold from 13 investors of a $15,000,000 total offering as of the Form D filed October 17, 2023. The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $50,000. The Form D names Emerson Equity LLC (CRD 130032), associated with None as the recipient of sales compensation soliciting in all states. The issuer's address of record is 1776 Yorktown St, Suite 700, Houston, TX 77056.
EDGAR Filing Data
Form D — Primary Source
View on SEC.govFilings on Record
Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.
In the Terminal
Filing events
0
none on file
Critical / warning
0 / 0
0 watch · 0 info
Statements extracted
0
none on file
NAV prints
0
none on file
Offering chains
6
closed, lapsed
Investor
- 6 offering timelines: velocity, share raised, first-sale lag, stalled flags
Pro
- This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
- The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV
Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…
Related Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
Item 3 changed on the Form D filed 2023-10-17: 3 related persons added and 6 removed against the filing of 2022-04-12; 10 now listed. The names are in the Terminal feed.
Thomas Vo
Executive Officer, Director · Houston, TX
Warren Hosseinionn
Executive Officer, Director · Houston, TX
Jon Bates
Executive Officer · Houston, TX
Mitchell Creem
Director · Houston, TX
Cheryl Grenas
Director · Houston, TX
Michael Reed
Director · Houston, TX
John Waters
Director · Houston, TX
Danniel Stites
Director · Houston, TX
Elisa Luqman
Executive Officer · Houston, TX
Pamela Montgomery
Executive Officer · Houston, TX
Placement Agents and Sales Compensation (Form D)
Who the issuer reported paying to sell the securities (Form D Item 12), with the FINRA registration number the filer gave. Source: SEC.gov.
Emerson Equity LLCCRD 130032 on BrokerCheck
Associated broker-dealer: None · San Mateo, CA · Soliciting in all states and outside the United States
Questions About Nutex Health, Inc.
Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.
What is Nutex Health, Inc.?
Nutex Health, Inc. is a Delaware corporation that filed a Form D with the SEC on October 17, 2023 in the Hospitals and Physicians industry group. The filing claims Rule 506(b) for an offering of debt.
Is Nutex Health, Inc. legit?
AltStreet does not rate legitimacy; it reports the public record. Nutex Health, Inc. filed a Form D with the SEC on October 17, 2023 claiming Rule 506(b). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $3,090,000 sold to 13 investors. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.
Is Nutex Health, Inc. registered with or approved by the SEC?
No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that Nutex Health, Inc. claimed Rule 506(b) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.
How much has Nutex Health, Inc. raised?
Nutex Health, Inc. reported $3,090,000 sold from 13 investors of a $15,000,000 total offering as of the Form D filed October 17, 2023.
Who can invest in Nutex Health, Inc.?
The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $50,000.
What is the minimum investment in Nutex Health, Inc.?
The Form D lists $50,000 as the minimum investment accepted from any outside investor as of October 17, 2023. Issuers can waive their own minimums, and the figure does not include fees.
Who is selling Nutex Health, Inc. and how are they paid?
The Form D names Emerson Equity LLC (CRD 130032), associated with None as the recipient of sales compensation soliciting in all states.
Who is behind Nutex Health, Inc.?
The Form D lists 10 related persons: Thomas Vo, executive officer, director; Warren Hosseinionn, executive officer, director; Jon Bates, executive officer; Mitchell Creem, director; Cheryl Grenas, director; Michael Reed, director; John Waters, director; Danniel Stites, director, and 2 more. Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.
Where is Nutex Health, Inc. located?
The issuer's address on its SEC filings is 1776 Yorktown St, Suite 700, Houston, TX 77056. Its phone number of record is (713) 660-0557. It is organized under the laws of Delaware.
How long is the Nutex Health, Inc. offering open?
The issuer indicated that the offering is not intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open; 2 amendments are on record for this CIK.
What is Nutex Health, Inc.'s revenue?
The issuer declined to disclose its revenue range on the Form D, which the form permits.
Is this your company or fund?
Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.
Verified Issuer, $480 a year: AltStreet checks the identity of your company and the authority of the person claiming it against your filings, confirms your contact details on a stated date and again at each renewal, and marks the page so people researching you find a current, attributed profile beside the public filing record. It is not a review of any offering.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.